Barely Significant
← all excerpts

Re-emerging role of macroscopic appearance in treatment strategy for gastric cancer.

Ann Gastroenterol Surg · 2019 · PMC6422795 · PMID 30923781

Europe PMCDOI
1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

showed a trendP = 0.08so close (0.05 < p ≤ 0.1)
chemotherapy with adjuvant chemotherapy showed a trend toward improvement in overall survival (HR 0.70; 95% CI 0.47‐1.04; P = 0.08). 61 Ishigami et al. conducted a phase III trial comparing i.p. and i.v. paclitaxel plus S‐1 (IP) versus cisplatin plus S‐1 (SP) in patients with peritoneal metastasis. 62 Although this trial failed to show statistical superiority of intraperitoneal paclitaxel plus systemic chemotherapy, the 3‐year overall survival rate was 21.9% (95% CI, 14.9%‐29.9%) in the IP arm and 6.0% (95% CI, 1.6%‐14.9%) in the SP arm.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.